| Isolation and characterization of patient-derived, toxic, high mass amyloid β-protein (Aβ) assembly from Alzheimer disease brains A Noguchi, S Matsumura, M Dezawa, M Tada, M Yanazawa, A Ito, ... Journal of Biological Chemistry 284 (47), 32895-32905, 2009 | 226 | 2009 |
| Early development of autonomic dysfunction may predict poor prognosis in patients with multiple system atrophy M Tada, O Onodera, M Tada, T Ozawa, YS Piao, A Kakita, H Takahashi, ... Archives of neurology 64 (2), 256-260, 2007 | 169 | 2007 |
| Na, K-ATPase α3 is a death target of Alzheimer patient amyloid-β assembly T Ohnishi, M Yanazawa, T Sasahara, Y Kitamura, H Hiroaki, Y Fukazawa, ... Proceedings of the National Academy of Sciences 112 (32), E4465-E4474, 2015 | 143 | 2015 |
| Cerebellar involvement in progressive supranuclear palsy: a clinicopathological study M Kanazawa, T Shimohata, Y Toyoshima, M Tada, A Kakita, T Morita, ... Movement disorders: official journal of the Movement Disorder Society 24 (9 …, 2009 | 141 | 2009 |
| Depletion of medullary serotonergic neurons in patients with multiple system atrophy who succumbed to sudden death M Tada, A Kakita, Y Toyoshima, O Onodera, T Ozawa, T Morita, ... Brain 132 (7), 1810-1819, 2009 | 123 | 2009 |
| Haploinsufficiency of CSF-1R and clinicopathologic characterization in patients with HDLS T Konno, M Tada, M Tada, A Koyama, H Nozaki, Y Harigaya, J Nishimiya, ... Neurology 82 (2), 139-148, 2014 | 122 | 2014 |
| Expression of aquaporin 1 and aquaporin 4 in the temporal neocortex of patients with Parkinson's disease A Hoshi, A Tsunoda, M Tada, M Nishizawa, Y Ugawa, A Kakita Brain Pathology 27 (2), 160-168, 2017 | 74 | 2017 |
| Pathology and sensitivity of current clinical criteria in corticobasal syndrome H Ouchi, Y Toyoshima, M Tada, M Oyake, I Aida, I Tomita, A Satoh, ... Movement Disorders 29 (2), 238-244, 2014 | 62 | 2014 |
| Altered expression of glutamate transporter‐1 and water channel protein aquaporin‐4 in human temporal cortex with Alzheimer's disease A Hoshi, A Tsunoda, T Yamamoto, M Tada, A Kakita, Y Ugawa Neuropathology and applied neurobiology 44 (6), 628-638, 2018 | 60 | 2018 |
| Coexistence of Huntington’s disease and amyotrophic lateral sclerosis: a clinicopathologic study M Tada, EA Coon, AP Osmand, PA Kirby, W Martin, M Wieler, A Shiga, ... Acta neuropathologica 124, 749-760, 2012 | 58 | 2012 |
| Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia M Kanazawa, M Tada, O Onodera, H Takahashi, M Nishizawa, ... Parkinsonism & Related Disorders 19 (12), 1149-1151, 2013 | 56 | 2013 |
| The phenotype spectrum of Japanese multiple system atrophy T Ozawa, M Tada, A Kakita, O Onodera, T Ishihara, T Morita, T Shimohata, ... Journal of Neurology, Neurosurgery & Psychiatry 81 (11), 1253-1255, 2010 | 56 | 2010 |
| Heterogeneity of cerebral TDP-43 pathology in sporadic amyotrophic lateral sclerosis: evidence for clinico-pathologic subtypes R Takeuchi, M Tada, A Shiga, Y Toyoshima, T Konno, T Sato, H Nozaki, ... Acta neuropathologica communications 4, 1-13, 2016 | 52 | 2016 |
| Characteristic microglial features in patients with hereditary diffuse leukoencephalopathy with spheroids M Tada, T Konno, M Tada, T Tezuka, T Miura, N Mezaki, K Okazaki, ... Annals of Neurology 80 (4), 554-565, 2016 | 52 | 2016 |
| Long-term therapeutic efficacy and safety of low-dose tacrolimus (FK506) for myasthenia gravis M Tada, T Shimohata, M Tada, M Oyake, S Igarashi, O Onodera, ... Journal of the neurological sciences 247 (1), 17-20, 2006 | 46 | 2006 |
| Phosphorylated TDP-43 aggregates in skeletal and cardiac muscle are a marker of myogenic degeneration in amyotrophic lateral sclerosis and various conditions F Mori, M Tada, T Kon, Y Miki, K Tanji, H Kurotaki, M Tomiyama, ... Acta neuropathologica communications 7, 1-12, 2019 | 43 | 2019 |
| Relocation of p25α/tubulin polymerization promoting protein from the nucleus to the perinuclear cytoplasm in the oligodendroglia of sporadic and COQ2 mutant … K Ota, M Obayashi, K Ozaki, S Ichinose, A Kakita, M Tada, H Takahashi, ... Acta neuropathologica communications 2, 1-19, 2014 | 42 | 2014 |
| Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3 M Prudencio, H Garcia-Moreno, KR Jansen-West, RH Al-Shaikh, ... Science translational medicine 12 (566), eabb7086, 2020 | 37 | 2020 |
| Difference in MSA phenotype distribution between populations: genetics or environment? T Ozawa, T Revesz, D Paviour, AJ Lees, N Quinn, M Tada, A Kakita, ... Journal of Parkinson's Disease 2 (1), 7-18, 2012 | 37 | 2012 |
| Globular glial mixed four repeat tau and TDP‐43 proteinopathy with motor neuron disease and frontotemporal dementia R Takeuchi, Y Toyoshima, M Tada, H Tanaka, H Shimizu, A Shiga, ... Brain Pathology 26 (1), 82-94, 2016 | 30 | 2016 |
